RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-7.57%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.97B
AUM Growth
+$3.97B
(-8.2%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
30.63%
Holding
141
New
5
Increased
76
Reduced
8
Closed
5
Top Buys
| 1 |
DexCom
DXCM
|
$24.2M |
| 2 |
Idexx Laboratories
IDXX
|
$21.2M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$18.1M |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
$12.8M |
| 5 |
Penumbra
PEN
|
$12.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$18.8M |
| 2 |
Intuitive Surgical
ISRG
|
$18.6M |
| 3 |
Immuneering
IMRX
|
$17.6M |
| 4 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$13M |
| 5 |
XENT
Intersect ENT, Inc
XENT
|
$10.9M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Consumer Staples | 1.53% |
| 3 | Industrials | 0.67% |
| 4 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Agilon Health
AGL
$530M
| $194M | 4.88% | 7,640,000 +145,000 | +2% | +$3.68M |
|
2
Humana
HUM
$36.5B
| $160M | 4.04% | 368,600 +19,600 | +6% | +$8.53M |
|
3
Insulet
PODD
$23.9B
| $128M | 3.23% | 481,700 +17,950 | +4% | +$4.78M |
|
4
UnitedHealth
UNH
$281B
| $122M | 3.08% | 240,000 | – | – |
|
|
5
Idexx Laboratories
IDXX
$51.8B
| $120M | 3.01% | 218,750 +38,750 | +22% | +$21.2M |
|
6
argenx
ARGX
$43.6B
| $110M | 2.78% | 350,000 +35,000 | +11% | +$11M |
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $104M | 2.61% | 1,105,000 | – | – |
|
8
Align Technology
ALGN
$10.3B
| $94.4M | 2.38% | 216,500 +16,500 | +8% | +$7.19M |
|
|
9
HCA Healthcare
HCA
$94.5B
| $94M | 2.37% | 375,000 -75,000 | -17% | -$18.8M |
|
|
10
Intuitive Surgical
ISRG
$170B
| $90.1M | 2.27% | 298,500 -61,500 | -17% | -$18.6M |
|
|
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $78.5M | 1.98% | 746,000 | – | – |
|
12
Agios Pharmaceuticals
AGIO
$2.19B
| $77.6M | 1.95% | 2,665,275 +18,650 | +0.7% | +$543K |
|
13
Evolent Health
EVH
$1.12B
| $76.9M | 1.94% | 2,380,000 +342,000 | +17% | +$11M |
|
14
Pacira BioSciences
PCRX
$1.2B
| $76.3M | 1.92% | 1,000,000 | – | – |
|
15
Immunocore
IMCR
$1.62B
| $76.3M | 1.92% | 2,552,034 +80,479 | +3% | +$2.41M |
|
16
Ultragenyx Pharmaceutical
RARE
$2.89B
| $74.7M | 1.88% | 1,028,109 +144,188 | +16% | +$10.5M |
|
17
Edwards Lifesciences
EW
$47.8B
| $70.2M | 1.77% | 596,500 +14,500 | +2% | +$1.71M |
|
18
iRhythm Technologies
IRTC
$5.46B
| $68.7M | 1.73% | 436,000 +3,000 | +0.7% | +$472K |
|
19
Aclaris Therapeutics
ACRS
$209M
| $66.6M | 1.68% | 3,865,034 +3,687 | +0.1% | +$63.6K |
|
20
Freshpet
FRPT
$2.72B
| $60.8M | 1.53% | 592,500 +12,500 | +2% | +$1.28M |
|
|
BPMC
21
DELISTED
Blueprint Medicines
BPMC
| $60.5M | 1.52% | 947,715 +87,960 | +10% | +$5.62M |
|
|
CERE
22
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $60.3M | 1.52% | 1,723,341 +74,906 | +5% | +$2.62M |
|
23
Baxter International
BAX
$12.7B
| $58.2M | 1.47% | 750,700 +16,897 | +2% | +$1.31M |
|
|
SWAV
24
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $56.3M | 1.42% | 271,500 +49,000 | +22% | +$10.2M |
|
|
KRTX
25
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $54.8M | 1.38% | 432,543 +5,700 | +1% | +$723K |
|